Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr;25(16):2000460.
doi: 10.2807/1560-7917.ES.2020.25.16.2000460.

Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020

Marta Colaneri  1 , Paolo Sacchi  1 , Valentina Zuccaro  1 , Simona Biscarini  1 , Michele Sachs  1 , Silvia Roda  1 , Teresa Chiara Pieri  1 , Pietro Valsecchi  1 , Antonio Piralla  2 , Elena Seminari  1 , Angela Di Matteo  1 , Stefano Novati  1 , Laura Maiocchi  1 , Layla Pagnucco  1 , Marcello Tirani  2   3 , Fausto Baldanti  4   5 , Francesco Mojoli  5   6   7 , Stefano Perlini  8   9 , Raffaele Bruno  1   5 ; COVID19 IRCCS San Matteo Pavia Task Force  10
Affiliations
Comment

Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020

Marta Colaneri et al. Euro Surveill. 2020 Apr.

Abstract

We describe clinical characteristics, treatments and outcomes of 44 Caucasian patients with coronavirus disease (COVID-19) at a single hospital in Pavia, Italy, from 21-28 February 2020, at the beginning of the outbreak in Europe. Seventeen patients developed severe disease, two died. After a median of 6 days, 14 patients were discharged from hospital. Predictors of lower odds of discharge were age > 65 years, antiviral treatment and for severe disease, lactate dehydrogenase > 300 mg/dL.

Keywords: COVID-19; LDH; SARS-CoV-2; retrospective study; severe disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
    Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Corman VM, et al. Euro Surveill. 2020 Jan;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. Euro Surveill. 2020. PMID: 31992387 Free PMC article.

References

    1. World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: WHO. 11 Mar 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
    1. Johns Hopkins University & Medicine. Coronavirus Resource Center. Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Baltimore: Johns Hopkins University & Medicine. [Accessed: 20 Apr 2020]. Available from: https://coronavirus.jhu.edu/map.html
    1. Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. 10.1136/bmj.m606 - DOI - PMC - PubMed
    1. Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis. 2020. - PMC - PubMed
    1. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. - PMC - PubMed